Home > Journals > Minerva Gastroenterology > Past Issues > Minerva Gastroenterology 2021 June;67(2) > Minerva Gastroenterology 2021 June;67(2):196-208



Publishing options
To subscribe PROMO
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Gastroenterology 2021 June;67(2):196-208

DOI: 10.23736/S2724-5985.20.02747-6


language: English

Elastography for characterization of focal liver lesions: current evidence and future perspectives

Carolina MARTELLETTI 1, Angelo ARMANDI 1, Gian Paolo CAVIGLIA 2, Giorgio M. SARACCO 1, 2, 3, Rinaldo PELLICANO 3

1 School of Gastroenterology, Department of Medical Sciences, University of Turin, Turin, Italy; 2 Department of Medical Sciences, University of Turin, Turin, Italy; 3 Unit of Gastroenterology, Molinette-SGAS Hospital, Turin, Italy

Focal liver lesions (FLLs) are a common finding during routine abdominal ultrasound (US). The differential diagnosis between diverse types of FLLs, especially between benign and malignant ones, is extremely important and can often be particularly challenging. Radiological techniques with contrast administration and/or liver biopsy are mostly necessary for establishing diagnosis, but they have several contraindications or complications. Due to limitations of these tools, there is urgent and still unmet need to develop a first line, non-invasive and simple method to diagnose FLLs. Elastography is an US-based imaging modality that provides information about the physical parameter corresponding to the tissue stiffness and can be considered a virtual biopsy. Several elastographic approaches have been developed, such as transient elastography, strain imaging and share wave imaging, which include point shear wave elastography and 2D shear wave elastography. These tools are already in use for evaluating liver fibrosis and in the assessment of focal lesions in other organs, like breast and thyroid gland. This review aims to assess the current evidence of different techniques based on elastography in the setting of FLLs, in order to evaluate accuracy, limitations and future perspectives. In particular, we focused on two contexts: the ability of discriminating between benign and malignant lesions, especially hepatocellular carcinoma and liver metastasis, and the surveillance after percutaneous therapy. This could have a high clinical impact making elastography crucial to identify the appropriate management of FLLs.

KEY WORDS: Hepatic elastography; Hepatocellular carcinoma; Liver neopalsms, Fibrosis

top of page